MA38685A1 - Providing a pharmacokinetic drug dosing regimen - Google Patents
Providing a pharmacokinetic drug dosing regimenInfo
- Publication number
- MA38685A1 MA38685A1 MA38685A MA38685A MA38685A1 MA 38685 A1 MA38685 A1 MA 38685A1 MA 38685 A MA38685 A MA 38685A MA 38685 A MA38685 A MA 38685A MA 38685 A1 MA38685 A1 MA 38685A1
- Authority
- MA
- Morocco
- Prior art keywords
- dosing regimen
- providing
- plasma protein
- therapeutic plasma
- dosing
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
L'invention porte sur un système et un procédé permettant d'assurer un régime de dosage de protéines plasmatiques thérapeutiques, comprenant la détermination d'un profil pharmacocinétique d'un patient à l'aide d'un modèle bayesien de profils pharmacocinétiques de patients prélevés. Le système et le procédé pour exemple comprennent également la détermination d'un premier régime de dosage pour un premier intervalle de dosage spécifié comprenant (i) un premier dosage et (ii) un premier taux de protéines plasmatiques thérapeutiques chez le patient sur une période de temps sur la base au moins du profil pharmacocinétique et la détermination d'un second régime de dosage pour un second intervalle de dosage spécifié comprenant (i) un second dosage et (ii) un second taux de protéines plasmatiques thérapeutiques chez le patient sur la période de temps sur la base au moins du profil pharmacocinétique. Le système et le procédé pour exemple comprennent en outre l'affichage du premier régime de dosage et du second régime de dosage sur un dispositif client de façon à ce que le premier régime de dosage soit affiché conjointement avec le second régime de dosage.A system and method for providing a therapeutic plasma protein assay regime, comprising determining a pharmacokinetic profile of a patient using a Bayesian model of pharmacokinetic profiles of patients sampled . The exemplary system and method also includes determining a first dosing regimen for a first specified dosing interval comprising (i) a first dosage and (ii) a first therapeutic plasma protein level in the patient over a period of time. at least on the basis of the pharmacokinetic profile and the determination of a second dosing regimen for a second specified dosing interval comprising (i) a second assay and (ii) a second therapeutic plasma protein level in the patient over the period time based on at least the pharmacokinetic profile. The exemplary system and method further includes displaying the first dosing regimen and the second dosing regimen on a client device so that the first dosing regimen is displayed together with the second dosing regimen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361837421P | 2013-06-20 | 2013-06-20 | |
PCT/US2014/043517 WO2015006033A1 (en) | 2013-06-20 | 2014-06-20 | Providing a pharmacokinetic drug dosing regime |
Publications (2)
Publication Number | Publication Date |
---|---|
MA38685A1 true MA38685A1 (en) | 2017-10-31 |
MA38685B2 MA38685B2 (en) | 2020-05-29 |
Family
ID=60765491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA38685A MA38685B2 (en) | 2013-06-20 | 2014-06-20 | Provision of a pharmacokinetic drug dosing regimen |
Country Status (1)
Country | Link |
---|---|
MA (1) | MA38685B2 (en) |
-
2014
- 2014-06-20 MA MA38685A patent/MA38685B2/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA38685B2 (en) | 2020-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2017272293B2 (en) | Providing a pharmacokinetic drug dosing regimen | |
WO2018185727A3 (en) | An injection location and/or dosage determination device and system for a liquid drug administration device or system | |
EP4309713A3 (en) | Systems for delivery of therapeutic gas | |
BR112018070463A8 (en) | METHOD AND APPARATUS FOR PROVIDING A PHARMACOKINETIC DRUG DOSAGE REGIME | |
MA43615A1 (en) | Motorized injection device for administering multiple liquid formulations, including vaccines | |
FR3018446B1 (en) | IMPROVEMENT FOR CANAL IRRIGATION NEEDLE | |
MA38972B1 (en) | Methods and tools for administering a contrast medium | |
MA38685A1 (en) | Providing a pharmacokinetic drug dosing regimen | |
MA55077A (en) | DRUG DELIVERY DEVICE WITH DETECTION SYSTEM | |
WO2017167942A8 (en) | Method for predicting the response of melanoma patients to a medicament | |
FI20176160A1 (en) | Device and method for measuring and recording a dose of medicine in a medicine dosing device | |
FR2894149B1 (en) | METHOD FOR DETECTING OCCLUSION OF A TUBE FOR APPARATUS FOR DELIVERING PHYSIOLOGICAL LIQUIDS | |
EA202190596A2 (en) | PROVISION OF A PHARMACOKINETIC DRUG DOSAGE SCHEME | |
Papageorgiou | Meta-analysis 101 | |
Keskin | Sterile abscesses: case report | |
Can | Tenofovir disoproxil fumarate | |
Ransohoff | Drug resistance leading to switching of basal-cell carcinoma to squamous-cell carcinoma: case report | |
TH160649B (en) | Machines and methods for pharmacokinetic dosing requirements | |
Karger | First report of serotonin-secreting neuroendocrine neoplasm and elevated serum chromogranin A level: case report | |
Tolar et al. | Gingival Crevicular Fluid Volume in Patients Treated With Invisalign | |
YU et al. | Pendular nystagmus and palatal myoclonus from hypertrophic olivary degeneration after hemorrhage of the brain stem | |
TH160649A (en) | Machines and methods for pharmacokinetic dosing requirements | |
Falanga | Paracetamol/warfarin interaction | |
Umayahara | Acute generalised exanthematous pustulosis in a child: case report | |
Figueroa | Angioedema: case report |